Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
Minyan Wei,1,2 Xiucai Guo,1,3 Liuxiao Tu,1 Qi Zou,1 Qi Li,1 Chenyi Tang,1 Bao Chen,1 Yuehong Xu,1 Chuanbin Wu1 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Sun Yat-sen University, 2Department of Pharmaceutics, School of Pharmaceutical Sciences, Guangzhou Medical University, 3Dep...
Guardado en:
Autores principales: | Wei MY, Guo XC, Tu LX, Zou Q, Li Q, Tang CY, Chen B, Xu YH, Wu CB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8905c217601542e4966e17366eb01a6d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Reactive Oxygen Species-Mediated Inflammation and Apoptosis in Hand-Foot Syndrome Induced by PEGylated Liposomal Doxorubicin
por: Hu X, et al.
Publicado: (2021) -
Safety and efficacy of pegylated liposomal doxorubicin in HIV-associated Kaposi’s sarcoma
por: Francesca Cainelli, et al.
Publicado: (2009) -
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
por: Zhou X, et al.
Publicado: (2012) -
Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles
por: Rangger C, et al.
Publicado: (2012) -
Renal-targeted delivery of triptolide by entrapment in pegylated TRX-20-modified liposomes
por: Yuan Z, et al.
Publicado: (2017)